Tag Archives: Anemia Drug
-
-
Aranesp, Procrit and Epogen Health Risks Call For Lower Doses: FDA
-
Epogen, Procrit May Increase Heart Attack Damage: Study
-
Use of Anemia Drugs for Kidney Failure Supported by FDA Panel
-
Procrit and Epogen Recall Issued Over Glass Flakes in Vials
-
Anemia Drugs Increase Risk of Heart Problems, Death in Some Cases: Study
-
Supreme Court Rejects Appeal of Procrit Whistleblower Lawsuit
-
Side Effects of Aranesp, Procrit and Epogen Lead to New FDA Restrictions
-
Aranesp, Epogen and Procrit Health Risks to be Reviewed Further by FDA
-
Aranesp, Epogen and Procrit Blood Clot Risk Confirmed: Study